BioSpace News Archive

Dr. Howard Landesman recognized by the American College of Prosthodontists.

AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has gained two new insurance customers in China for its cancer screening and detection tests (“CDA

Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, announced that it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) on February 4, 2020

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and year ended December 31, 2019.

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that management plans to present at two investor conferences for the remainder of the quarter.

Collegium Pharmaceutical, Inc. announced that it has entered into a definitive agreement to acquire the U.S. rights to the Nucynta Franchise from Assertio Therapeutics, Inc. for $375.0 million in cash..

Pacific Biosciences of California, Inc. announced financial results for its fourth quarter and year ended December 31, 2019, as attached.

Company Intends to Use Improved Balance Sheet to Pursue Business Development, Strategic Partnerships and Investment Opportunities

Therapix Biosciences Ltd. announced that on February 5, 2020, it received notice that the Nasdaq Hearings Panel granted the Company an extension until April 1, 2020, to regain compliance with the minimum $2,500,000 stockholders’ equity requirement for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5550.

Brooks Automation, Inc., a leader in automation solutions for the semiconductor manufacturing and life sciences industries, reported financial results for the first fiscal quarter of 2020, ended December 31, 2019.